Controlling rat populations and the diseases associated with them has been a concern for centuries, underlined in the public consciousness by historical plagues believed to be spread by rats, including the 14th century “Black Death” that remains the most fatal pandemic recorded in human history, causing the deaths of 75–200 million people (https://ibn.fm/DdhRa). In the […]

SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, is bolstering its executive team as it eyes the global nutraceuticals market, which is expected to post a CAGR of 9.4% between 2023 and 2030, and the global NSAID market which is also expected to be valued at $30 billion by 2030. SOHM’s strategic approach […]

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its Gold Sponsorship of The BRAIN Foundation’s esteemed Synchrony Symposia 2023. The BRAIN Foundation supports translational research that will lead to […]

October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov, were awarded the 2023 Nobel Prize in Chemistry for their discovery and synthesis of tiny clusters of atoms known as quantum dots, which are widely used today in […]

The trending nature of advanced conversational intelligence has granted it a growing wave of media gravitas in recent months, including a September report by The Intelligence. The report noted that communications technology mega cap company Apple is investing “millions of dollars a day” to further develop conversational intelligence features in its products such as the […]

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its intention to launch new human and animal studies that will explore its patented DehydraTECH(TM) technology on glucagon-like peptide-1 (“GLP-1”) drugs for improved bioavailability, cost-effectiveness, tolerability, weight loss potential, management of diabetes and other health conditions. Regarded as a significant expansion for […]

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF), a mineral exploration with multiple rare earths and uranium projects in mining-friendly jurisdictions, including Goiás State, Brazil and Saskatchewan and Ontario, Canada, took a “significant step in cementing itself among the upper tier of critical mineral explorers,” according to company President Stephen Burega, when it entered […]

Serious investors — and anyone concerned with protecting and building wealth in volatile times — invited to attend the New Orleans Investment Conference to be held in New Orleans, November 1-4, 2023. With a rich legacy spanning almost 50 years, the New Orleans Investment Conference has been acclaimed as “The Greatest Investment Show on Earth” […]

GolfLync, one of the hottest and fastest-growing social networking platforms for golf enthusiasts, has announced that enrollment has surpassed 75,000 members across the United States. This monumental growth underscores the company’s mission and ability to unite golfers, creating dynamic golfing communities that continue to thrive. GolfLync’s revolutionary Virtual Golf Clubs(TM) (“VGCs”) have reshaped how golfers […]

Once threatened by the sudden COVID-induced closure of businesses and restaurants, which forced rats to adapt by moving to residential areas in search of food or die – renowned rodentologist Bobby Corrigan estimates that hundreds of thousands, if not millions, died – the long-tailed rodents are now seemingly enjoying a change of fortune. Rat populations […]